AstraZeneca Pharma India plans to sell Bengaluru plant – ET HealthWorld | Pharma
AstraZeneca Pharma India plans to sell its production facility in Bengaluru as part of a strategic review of global manufacturing…
Fast News Hear
AstraZeneca Pharma India plans to sell its production facility in Bengaluru as part of a strategic review of global manufacturing…
New Delhi: Merck & Co. agreed to buy the rights to sell Daiichi Sankyo Co.’s three experimental cancer drugs as…
London: UK’s FTSE 100 inched higher on Friday as healthcare and consumer staples stocks gained, while investors were relieved that…
London: Drugmaker Viatris Inc warned on Thursday that it will stop selling some essential medicines in the UK that are…
New Delhi: Merck & Co Inc and British drugmaker AstraZeneca PLC said on Thursday that an independent committee of advisers…
Accept the updated privacy & cookie policy Dear user, ET HealthWorld privacy and cookie policy has been updated to align…
South Korea on Thursday said it will conduct a clinical trial that mixes Covid-19 vaccine doses developed by AstraZeneca Plc…
The United States will donate a significant number of Covid-19 vaccines through the World Health Organization‘s COVAX scheme for distributing…
Mixing doses of two leading Covid-19 vaccines increased patients’ side effects such as fatigue and headaches in early findings from…
One dose of Covid-19 vaccines from AstraZeneca Plc and Pfizer was 86.6% effective in preventing infections among people aged 60…